A patent infringement suit filed by Merck & Co. Inc. against Teva
Parenteral Medicines, Inc. relating to Cancidas is ongoing, Merck
disclosed in its August 8, 2011, Form 10-Q filing…
provides in-depth news coverage of intellectual property lawsuits involving public companies with assets of USD $1 billion or more. Coverage focuses on the infringement of intellectual property rights (including patents, copyrights, trademarks, trade dress, trade secrets, and royalties) and corporate indemnification of intellectual property violations.